These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25536928)

  • 1. Potential savings in prescription drug costs for hypertension, hyperlipidemia, and diabetes mellitus by equivalent drug substitution in Austria: a nationwide cohort study.
    Heinze G; Hronsky M; Reichardt B; Baumgärtel C; Müllner M; Bucsics A; Winkelmayer WC
    Appl Health Econ Health Policy; 2015 Apr; 13(2):193-205. PubMed ID: 25536928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
    Heinze G; Jandeck LM; Hronsky M; Reichardt B; Baumgärtel C; Bucsics A; Müllner M; Winkelmayer WC
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):90-9. PubMed ID: 26468002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of drug usage and expenditure in a hospital diabetes clinic.
    Wu SY; Lung BC; Chang S; Lee SC; Critchley JA; Chan JC
    J Clin Pharm Ther; 1998 Feb; 23(1):49-56. PubMed ID: 9756112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study.
    Tian Y; Reichardt B; Dunkler D; Hronsky M; Winkelmayer WC; Bucsics A; Strohmaier S; Heinze G
    Sci Rep; 2020 Apr; 10(1):5964. PubMed ID: 32249786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland.
    Tilson L; Bennett K; Barry M
    Eur J Health Econ; 2005 Sep; 6(3):267-73. PubMed ID: 15977036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much could be saved in Chinese hospitals in procurement of anti-hypertensives and anti-diabetics?
    Sun J; Ren L; Wirtz V
    J Med Econ; 2016 Sep; 19(9):881-8. PubMed ID: 27100310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
    Tuppin P; Ricci-Renaud P; de Peretti C; Fagot-Campagna A; Gastaldi-Menager C; Danchin N; Alla F; Allemand H
    Arch Cardiovasc Dis; 2013 May; 106(5):274-86. PubMed ID: 23769402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA; Li P; Desai S; Marcus SC
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
    Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prescribing behavior of primary care physicians in diabetes therapy: effect of drug budgeting].
    Jünger C; Rathmann W; Giani G
    Dtsch Med Wochenschr; 2000 Feb; 125(5):103-9. PubMed ID: 10705882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India.
    Chugh PK; Gupta P; Wasan H; Tripathi CD; Chandy SJ; Ranjalkar J; Bright HR; Badyal DK; Samuel MP; Jhaj R; Banerjee A; Joshi R; Medhi B; Prakash A; Kamat S; Tripathi R; Shetty Y; Parmar U; Dikshit H; Mishra H; Roy SS; Kumar R; Chatterjee S; Bhattacharya M; Samanta K; Trivedi N; Shah P; Chauhan J; Ramasamy R; Mathaiyan J; Gauthaman J; Kaushal S; Jain S; Arora S; Gupta K; Cherian JJ; Chatterjee NS; Kshirsagar NA
    Indian J Pharmacol; 2024 Mar; 56(2):97-104. PubMed ID: 38687313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term medication cost savings for treating hypertension and diabetes after gastric bypass.
    Ghiassi S; Morton J; Bellatorre N; Eisenberg D
    Surg Obes Relat Dis; 2012; 8(3):269-74. PubMed ID: 21723203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential savings without compromising the quality of care.
    Norman C; Zarrinkoub R; Hasselström J; Godman B; Granath F; Wettermark B
    Int J Clin Pract; 2009 Sep; 63(9):1320-6. PubMed ID: 19691615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand.
    Limwattananon C; Waleekhachonloet O
    PLoS One; 2019; 14(2):e0211759. PubMed ID: 30785916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health care too costly? Saving more than 10 million euros in 2 months!].
    Rappert B
    MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
    [No Abstract]   [Full Text] [Related]  

  • 17. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System.
    Gellad WF; Good CB; Lowe JC; Donohue JM
    Am J Manag Care; 2010 Oct; 16(10):741-50. PubMed ID: 20964470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis.
    Fretheim A; Aaserud M; Oxman AD
    BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic implications of evidence-based prescribing for hypertension: can better care cost less?
    Fischer MA; Avorn J
    JAMA; 2004 Apr; 291(15):1850-6. PubMed ID: 15100203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.